These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 16499996

  • 1. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
    Stinchcombe TE, Morris DE, Moore DT, Bechtel JH, Halle JS, Mears A, Deschesne K, Rosenman JG, Socinski MA.
    Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
    [Abstract] [Full Text] [Related]

  • 2. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
    Zhao L, West BT, Hayman JA, Lyons S, Cease K, Kong FM.
    Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):103-10. PubMed ID: 17363189
    [Abstract] [Full Text] [Related]

  • 3. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH, Ahn SJ, Pyo HR, Kim KS, Kim YC, Moon SH, Han JY, Kim HT, Koom WS, Lee JS.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1397-404. PubMed ID: 19117690
    [Abstract] [Full Text] [Related]

  • 4. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.
    Southeast Asian J Trop Med Public Health; 2005 Jul 01; 36(4):994-1006. PubMed ID: 16295558
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M, Aristu J, López-Picazo JM, Ramos LI, Gúrpide A, Gómez-Iturriaga A, Valero J, Martínez-Monge R.
    Radiother Oncol; 2008 Sep 01; 88(3):342-50. PubMed ID: 18558448
    [Abstract] [Full Text] [Related]

  • 10. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
    Huang EH, Liao Z, Cox JD, Guerrero TM, Chang JY, Jeter M, Borghero Y, Wei X, Fossella F, Herbst RS, Blumenschein GR, Moran C, Allen PK, Komaki R.
    Int J Radiat Oncol Biol Phys; 2007 Jul 01; 68(3):779-85. PubMed ID: 17418967
    [Abstract] [Full Text] [Related]

  • 11. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
    Wakelee HA, Bernardo P, Johnson DH, Schiller JH.
    Cancer; 2006 May 15; 106(10):2208-17. PubMed ID: 16604529
    [Abstract] [Full Text] [Related]

  • 12. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
    Dehing-Oberije C, Yu S, De Ruysscher D, Meersschout S, Van Beek K, Lievens Y, Van Meerbeeck J, De Neve W, Rao B, van der Weide H, Lambin P.
    Int J Radiat Oncol Biol Phys; 2009 Jun 01; 74(2):355-62. PubMed ID: 19095367
    [Abstract] [Full Text] [Related]

  • 13. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
    Higgins K, Chino JP, Marks LB, Ready N, D'Amico TA, Clough RW, Kelsey CR.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1462-7. PubMed ID: 19467798
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
    Zhou DH, Lin LZ, Zhou YQ, Luo RC, Liu KF, Jia YJ, Chen JY, Niu XW, Su BR, Lu J, Wang ST.
    Ai Zheng; 2005 Oct 01; 24(10):1252-6. PubMed ID: 16219143
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Oct 01; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 19. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.
    Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK.
    Cancer; 2006 Jun 01; 106(11):2428-36. PubMed ID: 16634096
    [Abstract] [Full Text] [Related]

  • 20. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
    Li Q, Gao JM, Liang PY, Xie FY, Liu GZ.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1463-6. PubMed ID: 15566658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.